Popular psych drugs linked to cancer.
An estimated 49 million Americans are currently taking psychotropic drugs to deal with mental health issues.
Depression, anxiety and behavioral problems are on the rise, and so too are the medications that treat them.
But how many of these 49 million realize that the pill they take every day could be increasing their risk of cancer?
Published in the Australian & New Zealand Journal of Psychiatry, a new review has shed light on the problem with psych drugs.
The team of international researchers found that many of the most popular psych drugs are, in fact carcinogenic.
Anti-convulsants and antipsychotics were found to be the most harmful, with benzodiazepines and antidepressants close behind.
Because of the problems that occur when testing for cancer links and the normal ethical problems that surround clinical trials, lab rodents were used in the study.
Most of the data we have for health studies involve animal testing of some kind, and although many agree this is unethical, it is usually the only way tests can be carried out.
The International Agency for Research on Cancer via the World Health Organization state:
“Although this association cannot establish that all agents and mixtures that cause cancer in experimental animals also cause cancer in humans, nevertheless, in the absence of adequate data on humans, it is biologically plausible and prudent to regard agents and mixtures for which there is sufficient evidence of carcinogenicity in experimental animals as if they presented a carcinogenic risk to humans”.
Which meds are the worst?
The study was conducted on a range of prevalent psych drugs, and the results were as follows–
• 63.6% of antidepressants are associated with carcinogenicity, specifically mirtazapine (Remeron), sertraline (Zoloft), paroxetine (Paxil), citalopram (Celexa), escitalopram (Lexapro), duloxetine (Cymbalta) and bupropion (Wellbutrin).
• 90% of antipsychotics agents are associated with carcinogenicity, including aripiprazole (Abilify), quetiapine (Seroquel) and all others in this class except for clozapine (Clozaril).
• 70% of benzodiazepines/hypnotics are associated with carcinogenicity, specifically clonazepam (Klonopin), zolpidem (Ambien), zaleplon (Sonata), diazepam (Valium), eszopiclone (Lunesta), oxazepam (Serax) and midazolam (Versed).
• 25% of amphetamines/stimulants are associated with carcinogenicity, specifically methylphenidate (Ritalin).
• 85.7% of anti-convulsants (“mood stabilizers”) are associated with carcinogenicity, specifically valproate (Depacon), carbamazepine (Tegretol), gabapentin (Neurontin), pregabalin (Lyrica), oxcarbazepine (Trileptal) and topiramate (Topamax).
As well as the cancer risk, there is a body of evidence to suggest that many pysch drugs actually leave the patient worse off in terms of long term health, is it time that we ended our love affair with these pills?
Via Wake Up World